INVESTING INSIGHTS & ANALYSIS
Below is an archive of our professional insight and analysis that will help you unlock the wealth building power of private equity and early-stage investing.
Why 47% of founders regret getting paid
No one likes having their strings pulled. And that’s the risk with taking early money…
The End of Blockbuster Drugs?
How precision medicine could change drug companies forever
The Major Biotech Problem We All Can Help Solve
How investors like you will soon be able to get in earlier than ever in promising biotechs.
Big Tech in Big Medicine
How the tech giants are making wave in healthcare
SEC Makes Major Crowdfunding Update
This is great news for all of us equity crowdfunders.
Is Telehealth TOO Hot?
The movement towards telehealth was accelerating even before COVID struck, with almost half of all doctors making use of it. But here we can see how hot this market really is…
The Digital Health Explosion
Here’s how you can prepare to take advantage of it…
Its Official! New Crowdfunding Rules Coming Into Play
It’s official. New crowdfunding amendments to go into effect March 15th, 2021
Why 2021 Could be a Breakout Year for Biotech
(hint: it has nothing to do with the pandemic)
Why 47% of founders regret getting paid
No one likes having their strings pulled. And that’s the risk with taking early money…
The End of Blockbuster Drugs?
How precision medicine could change drug companies forever
Don't make another private market investment without reading this...
The 5 Mistakes
investors make that crush returns
Download this free report now:
Just enter your name & email to access this report for free.
By submitting your email address you will receive access to this report and a free subscription to Equifund’s private investment newsletter. You can unsubscribe at any time and read more about our privacy policy here.
Advertisement:
Assure Health
- Personalized care that keeps seniors safe and healthy from home
Investment Highlights:
- 1
First-to-market remote patient care and telehealth platform that offers daily monitoring of qualified Medicare patients at no out-of-pocket cost.
- 2
Potential path to becoming a $1 billion company at current public market multiples.
- 3
Skyrocketing virtual medicine adoption rates -- especially among seniors -- thanks to COVID-19.
